Medical University of Warsaw clinical trial pipeline

3 trials changed in the last 30 days: 0 stopped, 2 with notable changes, 1 with a minor change only.

1. Notable

   Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP…Local, Targeted Therapy With Alpha Emitter [225Ac]Ac-DOTA-SP (TAT) in Glioma (WHO G3-G4) Progression

   Primary completion pushed from Sep 2026 to Sep 2027

   Also in this update: Study completion pushed from Sep 2027 to Sep 2028

   Medical University of Warsaw·Not applicable· NCT06975332· Registry history of NCT06975332 on ClinicalTrials.gov (opens the registry)

   Updated Oct 13, 2026

2. Notable

   EPA-DBS · Physical Activity on the Course of Parkinson's Disease…EPA-DBS · Physical Activity on the Course of Parkinson's Disease · Bilateral DBS-STN Stimulation

   Primary endpoint(s) modified

   Medical University of Warsaw·Not applicable· NCT07838636· Registry history of NCT07838636 on ClinicalTrials.gov (opens the registry)

   Updated Oct 6, 2026

• Stopped: an ongoing trial was terminated, suspended or withdrawn.
• Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
• Minor: routine progress and housekeeping, such as sites added or enrollment closed.